Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1676-86-4, (s)-benzyl (4-(2,5-dioxooxazolidin-4-yl)butyl)carbamate, Benzyl n-[4-[(4s)-2,5-dioxo-1,3-oxazolidin-4-yl]butyl]carbamate, (s)-4-[4-(cbz-amino)butyl]oxazolidine-2,5-dione, Mfcd16036317, Schembl7252817

Molecular Formula

C₁₅H₁₈N₂O₅

Molecular Weight

306.31 g/mol

InChI Key

HLLIDIRDRPSCHN-LBPRGKRZSA-N

1 2D Structure

Lys(Z)-NCA

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

benzyl N-[4-[(4S)-2,5-dioxo-1,3-oxazolidin-4-yl]butyl]carbamate

2.1.2 InChI

InChI=1S/C15H18N2O5/c18-13-12(17-15(20)22-13)8-4-5-9-16-14(19)21-10-11-6-2-1-3-7-11/h1-3,6-7,12H,4-5,8-10H2,(H,16,19)(H,17,20)/t12-/m0/s1

2.1.3 InChI Key

HLLIDIRDRPSCHN-LBPRGKRZSA-N

2.1.4 Canonical SMILES

C1=CC=C(C=C1)COC(=O)NCCCCC2C(=O)OC(=O)N2

2.1.5 Isomeric SMILES

C1=CC=C(C=C1)COC(=O)NCCCC[C@H]2C(=O)OC(=O)N2

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 1676-86-4

2. (s)-benzyl (4-(2,5-dioxooxazolidin-4-yl)butyl)carbamate

3. Benzyl N-[4-[(4s)-2,5-dioxo-1,3-oxazolidin-4-yl]butyl]carbamate

4. (s)-4-[4-(cbz-amino)butyl]oxazolidine-2,5-dione

5. Mfcd16036317

6. Schembl7252817

7. Dtxsid20433230

8. Zinc59340250

9. Akos027322593

10. N-[(4s)-4-(2,5-dioxo-4-oxazolidinyl)butyl]carbamic Acid Phenylmethyl Ester

11. Hy-w092115

12. S11720

13. Bs-16191

14. Cs-0137983

15. L-n6-benzoyloxycarbonyl Lysine N-carboxyanhydride

16. (s)-benzyl(4-(2,5-dioxooxazolidin-4-yl)butyl)carbamate

17. Benzyl {4-[(4s)-2,5-dioxo-1,3-oxazolidin-4-yl]butyl}carbamate

18. Carbamic Acid, [4-(2,5-dioxo-4-oxazolidinyl)butyl]-, Phenylmethyl Ester,(s)-

2.3 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₁₅H₁₈N₂O₅
Molecular Weight	306.31 g/mol
XLogP3	1.8
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	8
Exact Mass	306.12157168 g/mol
Monoisotopic Mass	306.12157168 g/mol
Topological Polar Surface Area	93.7 Å²
Heavy Atom Count	22
Formal Charge	0
Complexity	407
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

ABOUT THIS PAGE

Find Lys(Z)-NCA manufacturers, exporters & distributors on PharmaCompass

Lys(Z)-NCA

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?